|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 2.670 USD | -3.26% |
|
-9.80% | -88.64% |
| 09-02 | BioRestorative Therapies, Inc. Announces CEO Changes, Effective August 26, 2026 | CI |
| 09-02 | BioRestorative Therapies, Inc. Announces CFO Changes, Effective August 27, 2026 | CI |
Company Valuation: BioRestorative Therapies, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 3.401 | - | - |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -67.39% | - | - |
| Enterprise Value (EV) | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 3.401 | 3.401 | 3.401 |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -67.39% | 0% | 0% |
| P/E | -0.12x | -0.54x | -0.51x | -1.23x | -0.74x | -0.27x | -0.33x | -0.33x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | -0x | 0x | 0x | -0.27x |
| Capitalization / Revenue | 330x | 84.3x | 56.2x | 24.7x | 29x | 2.42x | 1.47x | 1.09x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.42x | 1.47x | 1.09x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.25x | -0.22x | -0.19x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -746 | -102.2 | -68.4 | -23.2 | -31.6 | -9.9 | -8.1 | -8.2 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.046 | 0.1198 | 0.1458 | 0.401 | 0.3597 | 1.405 | 2.312 | 3.125 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -26.31 | -18.97 | -15.22 | -11.56 | -15.65 | -13.61 | -15.67 | -17.97 |
| Net income 1 | -44.3 | -18.49 | -14.42 | -8.979 | -14.24 | -13.52 | -15.56 | -17.83 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 86.800 | 55.000 | 34.798 | 28.600 | 23.500 | 2.670 | 2.670 | 2.670 |
| Nbr of stocks (in thousands) | 175 | 184 | 235 | 346 | 444 | 1,274 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 4/1/24 | 3/28/25 | 3/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27x | - | - | - | 3.4M | |
| 19.64x | 6.93x | 13.92x | 1.51% | 66.93B | |
| 31.94x | 9.24x | 44.54x | 0.04% | 61.97B | |
| -79.21x | 15.29x | -73.77x | -.--% | 28.27B | |
| 28.46x | 6.03x | 15.64x | -.--% | 24.59B | |
| -14.63x | 5.3x | -6.66x | -.--% | 24.3B | |
| 26.45x | 4.98x | 16.56x | -.--% | 19.41B | |
| 48.28x | 17.79x | 36.09x | 0.31% | 16.77B | |
| 1225.47x | 35.26x | 769.42x | -.--% | 14.18B | |
| -15x | 3382.33x | -17.29x | -.--% | 14.01B | |
| Average | 127.11x | 387.02x | 88.72x | 0.21% | 27.04B | |
| Weighted average by Cap. | 73.54x | 185.02x | 49.63x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRTX Stock
- Valuation BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
